annual CAPEX:
$7.44B+$1.80B(+31.82%)Summary
- As of today (April 15, 2025), NVO annual capital expenditures is $7.44 billion, with the most recent change of +$1.80 billion (+31.82%) on December 31, 2024.
- During the last 3 years, NVO annual CAPEX has risen by +$6.27 billion (+533.51%).
- NVO annual CAPEX is now at all-time high.
Performance
NVO CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$2.32B+$412.97M(+21.62%)Summary
- As of today (April 15, 2025), NVO quarterly capital expenditures is $2.32 billion, with the most recent change of +$412.97 million (+21.62%) on December 31, 2024.
- Over the past year, NVO quarterly CAPEX has increased by +$424.06 million (+22.33%).
- NVO quarterly CAPEX is now -1.87% below its all-time high of $2.37 billion, reached on December 31, 2023.
Performance
NVO quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$7.44B-$44.19M(-0.59%)Summary
- As of today (April 15, 2025), NVO TTM capital expenditures is $7.44 billion, with the most recent change of -$44.19 million (-0.59%) on December 31, 2024.
- Over the past year, NVO TTM CAPEX has increased by +$315.85 million (+4.43%).
- NVO TTM CAPEX is now -0.59% below its all-time high of $7.49 billion, reached on September 30, 2024.
Performance
NVO TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
NVO CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.8% | +22.3% | +4.4% |
| 3 y3 years | +533.5% | +525.9% | +533.5% |
| 5 y5 years | +342.1% | +412.7% | +404.3% |
NVO CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +533.5% | -1.9% | +765.1% | -0.6% | +520.0% |
| 5 y | 5-year | at high | +533.5% | -1.9% | +1050.2% | -0.6% | +533.5% |
| alltime | all time | at high | +3823.2% | -1.9% | +4102.5% | -0.6% | >+9999.0% |
Novo Nordisk A/S CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $7.44B(+31.8%) | $2.32B(+21.6%) | $7.44B(-0.6%) |
| Sep 2024 | - | $1.91B(+0.6%) | $7.49B(+5.1%) |
| Jun 2024 | - | $1.90B(+44.7%) | $7.13B(+13.7%) |
| Mar 2024 | - | $1.31B(-44.6%) | $6.27B(+11.0%) |
| Dec 2023 | $5.65B(+170.0%) | $2.37B(+52.7%) | $5.65B(+34.1%) |
| Sep 2023 | - | $1.55B(+49.4%) | $4.21B(+31.6%) |
| Jun 2023 | - | $1.04B(+49.8%) | $3.20B(+27.1%) |
| Mar 2023 | - | $692.37M(-25.5%) | $2.52B(+20.3%) |
| Dec 2022 | $2.09B(+78.0%) | $929.81M(+72.8%) | $2.09B(+36.4%) |
| Sep 2022 | - | $538.12M(+51.6%) | $1.53B(+22.6%) |
| Jun 2022 | - | $354.95M(+32.2%) | $1.25B(+4.1%) |
| Mar 2022 | - | $268.52M(-27.7%) | $1.20B(+2.2%) |
| Dec 2021 | $1.18B(-65.3%) | $371.15M(+45.1%) | $1.18B(-57.2%) |
| Sep 2021 | - | $255.70M(-16.2%) | $2.75B(-21.0%) |
| Jun 2021 | - | $305.26M(+25.6%) | $3.48B(+3.1%) |
| Mar 2021 | - | $243.00M(-87.5%) | $3.37B(-0.3%) |
| Dec 2020 | $3.38B(+100.9%) | $1.94B(+97.1%) | $3.38B(+78.6%) |
| Sep 2020 | - | $985.16M(+387.8%) | $1.89B(+49.7%) |
| Jun 2020 | - | $201.96M(-20.6%) | $1.27B(-14.3%) |
| Mar 2020 | - | $254.37M(-43.9%) | $1.48B(-12.3%) |
| Dec 2019 | $1.68B(-14.3%) | $453.09M(+27.3%) | $1.68B(-10.5%) |
| Sep 2019 | - | $355.93M(-13.8%) | $1.88B(-3.8%) |
| Jun 2019 | - | $412.79M(-10.7%) | $1.96B(+0.9%) |
| Mar 2019 | - | $462.21M(-29.0%) | $1.94B(-1.3%) |
| Dec 2018 | $1.97B(+49.3%) | $651.39M(+51.3%) | $1.97B(+10.8%) |
| Sep 2018 | - | $430.43M(+8.7%) | $1.77B(+4.7%) |
| Jun 2018 | - | $396.01M(-18.8%) | $1.70B(+8.8%) |
| Mar 2018 | - | $487.99M(+6.0%) | $1.56B(+18.4%) |
| Dec 2017 | $1.32B(+7.1%) | $460.28M(+31.0%) | $1.32B(+4.5%) |
| Sep 2017 | - | $351.28M(+35.3%) | $1.26B(-2.6%) |
| Jun 2017 | - | $259.54M(+5.8%) | $1.29B(-0.9%) |
| Mar 2017 | - | $245.26M(-39.3%) | $1.31B(+6.2%) |
| Dec 2016 | $1.23B(+28.9%) | $403.78M(+4.8%) | $1.23B(-5.3%) |
| Sep 2016 | - | $385.21M(+42.1%) | $1.30B(+17.3%) |
| Jun 2016 | - | $271.11M(+60.7%) | $1.11B(+10.5%) |
| Mar 2016 | - | $168.70M(-64.3%) | $1.00B(+5.0%) |
| Dec 2015 | $953.04M(+23.9%) | $472.17M(+142.9%) | $953.04M(+25.9%) |
| Sep 2015 | - | $194.36M(+17.2%) | $756.87M(+1.6%) |
| Jun 2015 | - | $165.80M(+37.3%) | $744.86M(+0.3%) |
| Mar 2015 | - | $120.71M(-56.3%) | $742.58M(-3.4%) |
| Dec 2014 | $768.91M(+18.6%) | $276.00M(+51.4%) | $768.91M(+19.1%) |
| Sep 2014 | - | $182.35M(+11.5%) | $645.58M(-0.0%) |
| Jun 2014 | - | $163.52M(+11.2%) | $645.84M(+1.4%) |
| Mar 2014 | - | $147.04M(-3.7%) | $636.79M(-1.8%) |
| Dec 2013 | $648.32M(+3.6%) | $152.67M(-16.4%) | $648.32M(-8.0%) |
| Sep 2013 | - | $182.61M(+18.2%) | $704.79M(+2.2%) |
| Jun 2013 | - | $154.47M(-2.6%) | $689.54M(+0.6%) |
| Mar 2013 | - | $158.56M(-24.2%) | $685.14M(+9.5%) |
| Dec 2012 | $625.49M | $209.15M(+25.0%) | $625.49M(-4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | $167.35M(+11.5%) | $651.84M(+6.5%) |
| Jun 2012 | - | $150.08M(+51.7%) | $612.06M(+0.4%) |
| Mar 2012 | - | $98.92M(-58.0%) | $609.80M(-2.0%) |
| Dec 2011 | $622.43M(-10.1%) | $235.50M(+84.6%) | $622.43M(-3.5%) |
| Sep 2011 | - | $127.56M(-13.7%) | $645.04M(-4.8%) |
| Jun 2011 | - | $147.82M(+32.5%) | $677.53M(+4.1%) |
| Mar 2011 | - | $111.55M(-56.8%) | $650.68M(-6.0%) |
| Dec 2010 | $692.35M(+20.7%) | $258.11M(+61.3%) | $692.35M(+7.2%) |
| Sep 2010 | - | $160.05M(+32.3%) | $645.96M(-0.4%) |
| Jun 2010 | - | $120.98M(-21.0%) | $648.71M(+2.7%) |
| Mar 2010 | - | $153.22M(-27.6%) | $631.85M(+10.2%) |
| Dec 2009 | $573.61M(+42.5%) | $211.71M(+30.0%) | $573.61M(+11.2%) |
| Sep 2009 | - | $162.81M(+56.4%) | $515.91M(+17.3%) |
| Jun 2009 | - | $104.11M(+9.6%) | $439.79M(-0.6%) |
| Mar 2009 | - | $94.98M(-38.3%) | $442.23M(+9.9%) |
| Dec 2008 | $402.53M(-9.9%) | $154.01M(+77.6%) | $402.53M(+4.4%) |
| Sep 2008 | - | $86.69M(-18.6%) | $385.57M(-7.4%) |
| Jun 2008 | - | $106.55M(+92.8%) | $416.44M(-1.4%) |
| Mar 2008 | - | $55.28M(-59.7%) | $422.51M(-5.4%) |
| Dec 2007 | $446.71M(-20.0%) | $137.04M(+16.6%) | $446.71M(-8.2%) |
| Sep 2007 | - | $117.57M(+4.4%) | $486.54M(-5.6%) |
| Jun 2007 | - | $112.62M(+41.7%) | $515.50M(-4.9%) |
| Mar 2007 | - | $79.48M(-55.1%) | $541.85M(-3.0%) |
| Dec 2006 | $558.63M(-14.2%) | $176.88M(+20.7%) | $558.63M(-9.4%) |
| Sep 2006 | - | $146.52M(+5.4%) | $616.40M(-3.7%) |
| Jun 2006 | - | $138.97M(+44.4%) | $640.35M(+3.4%) |
| Mar 2006 | - | $96.26M(-59.0%) | $619.32M(-4.8%) |
| Dec 2005 | $650.71M(+23.1%) | $234.66M(+37.7%) | $650.71M(+3.0%) |
| Sep 2005 | - | $170.47M(+44.5%) | $631.71M(+4.2%) |
| Jun 2005 | - | $117.94M(-7.6%) | $606.49M(+2.5%) |
| Mar 2005 | - | $127.65M(-40.8%) | $591.47M(+11.9%) |
| Dec 2004 | $528.68M(+38.2%) | $215.65M(+48.5%) | $528.68M(+68.9%) |
| Sep 2004 | - | $145.25M(+41.1%) | $313.03M(+86.6%) |
| Jun 2004 | - | $102.92M(+58.7%) | $167.78M(+158.7%) |
| Mar 2004 | - | $64.86M | $64.86M |
| Dec 2003 | $382.55M(-23.9%) | - | - |
| Dec 2002 | $502.57M(+6.3%) | - | - |
| Dec 2001 | $472.89M(+61.2%) | - | - |
| Dec 2000 | $293.29M(+50.3%) | - | - |
| Dec 1999 | $195.09M(-26.0%) | - | - |
| Dec 1998 | $263.69M(-33.4%) | - | - |
| Dec 1997 | $395.85M(+12.1%) | - | - |
| Dec 1996 | $353.26M(+23.6%) | - | - |
| Dec 1995 | $285.79M(+4.4%) | - | - |
| Dec 1994 | $273.81M(-26.1%) | - | - |
| Dec 1993 | $370.54M(+14.3%) | - | - |
| Dec 1992 | $324.10M(+53.1%) | - | - |
| Dec 1991 | $211.63M(+11.5%) | - | - |
| Dec 1990 | $189.75M | - | - |
FAQ
- What is Novo Nordisk A/S annual capital expenditures?
- What is the all time high annual CAPEX for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual CAPEX year-on-year change?
- What is Novo Nordisk A/S quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly CAPEX year-on-year change?
- What is Novo Nordisk A/S TTM capital expenditures?
- What is the all time high TTM CAPEX for Novo Nordisk A/S?
- What is Novo Nordisk A/S TTM CAPEX year-on-year change?
What is Novo Nordisk A/S annual capital expenditures?
The current annual CAPEX of NVO is $7.44B
What is the all time high annual CAPEX for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual capital expenditures is $7.44B
What is Novo Nordisk A/S annual CAPEX year-on-year change?
Over the past year, NVO annual capital expenditures has changed by +$1.80B (+31.82%)
What is Novo Nordisk A/S quarterly capital expenditures?
The current quarterly CAPEX of NVO is $2.32B
What is the all time high quarterly CAPEX for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly capital expenditures is $2.37B
What is Novo Nordisk A/S quarterly CAPEX year-on-year change?
Over the past year, NVO quarterly capital expenditures has changed by +$424.06M (+22.33%)
What is Novo Nordisk A/S TTM capital expenditures?
The current TTM CAPEX of NVO is $7.44B
What is the all time high TTM CAPEX for Novo Nordisk A/S?
Novo Nordisk A/S all-time high TTM capital expenditures is $7.49B
What is Novo Nordisk A/S TTM CAPEX year-on-year change?
Over the past year, NVO TTM capital expenditures has changed by +$315.85M (+4.43%)